Cartilage News and Research

RSS

Cartilage is a stiff yet flexible connective tissue found in many areas in the bodies of humans and other animals, including the joints between bones, the rib cage, the ear, the nose, the elbow, the knee, the ankle, the bronchial tubes and the intervertebral discs.

Patent issued for nanotechnology bone biomaterial

Competitive Technologies announced today that patent number 6,808,561 has been issued by the US Patent Office for Dr. Brian R. Genge's nanotechnology bone biomaterial developed at the University of South Carolina (USC).

1 Nov 2004

Discovery affirms potential of stem cells for the development of possible therapies for spinal cord injury and nervous system disorders

Researchers at The Hospital for Sick Children (Sick Kids) have shown that stem cells found in adult skin retain their embryonic capability of making many types of cells.

1 Nov 2004

Atheromatosis, which lies behind heart attacks, stroke, and other cardiovascular problems, has a major impact on public health

These two diseases are completely different from each other, but they do have one common denominator: inflammation. Researchers at Lund University in Sweden can now show that it might also be possible to treat them with the same drug.

10 Oct 2004

Best approach for repairing breaks in bone separating brain from the nasal cavity is through the nasal cavity

The best approach for repairing breaks in the thin bone that separates the brain from the nasal cavity is through the nasal cavity, according to an analysis of 92 patients who had this increasingly common approach to treating a fortunately rare problem.

6 Oct 2004

Natural alternatives to osteoarthritis drug

The recall of Vioxx should come as a major sign of the need to look for safer alternatives for osteoarthritis treatment, according to the Director of the Australian Centre for complementary Medicine Education and Research (ACCMER), Professor Stephen Myers.

5 Oct 2004

New technique to treat condition called funnel chest, or pectus excavatum

Children and teenagers who suffer from a condition called funnel chest, or pectus excavatum, in which the chest wall becomes caved-in, now have a safe, effective and simpler surgical alternative to correct the condition, according to an article in a recent issue of the Annals of Thoracic Surgery.

4 Oct 2004

Magnetic resonance imaging helps measure osteoarthritis

Researchers from Australia's Monash University have revolutionised knee scans with the development of new technology that harnesses the power of magnetic resonance imaging (MRI).

10 Sep 2004

Patent issued for novel method to chill body tissues and organs without forming ice crystals

Body tissues such as blood vessels, cartilage and skin - even whole organs such as kidneys, livers and hearts - could become more widely available for transplants as a result of a patent issued recently to Organ Recovery Systems of Chicago for a method to chill body tissues and organs well below freezing without forming ice crystals.

30 Aug 2004

80% of cancer patients use some form of complementary or alternative therapies

Plug the terms "alternative" and "cancer" into Google and the Internet search engine returns a list of 3.27 million - yes, million - sites with information both credible and questionable about nontraditional treatments for cancer. What's a cancer patient to make of such a vast array of options?

18 Aug 2004

Osteoarthritis twice as likely if parents suffer the condition

New research published in the Annals of the Rheumatic Diseases, shows that children whose parents have osteoarthritis of the knee are twice as likely to develop the condition themselves. This research suggests that genetic make-up plays a role in osteoarthritis development.

12 Aug 2004

New knee-scanning procedures will provide more accurate diagnosis methods for doctors

New knee-scanning procedures developed by Australia's Monash University will provide more accurate diagnosis methods for doctors and save patients time and money.

10 Aug 2004

Study to determine how people with rheumatoid arthritis evaluate improvements in disease symptoms

The study will examine how much of an improvement in pain, stiffness, function and other symptoms is needed before patients consider the change important.

7 Aug 2004

A new marker for osteoarthritis

Osteoarthritis (OA) is a common, crippling age-related disease characterized by the gradual destruction of cartilage cushioning the joints.

5 Aug 2004

New clinical study to determine how people with rheumatoid arthritis evaluate improvements in disease symptoms

A new clinical study to determine how people with rheumatoid arthritis (RA) evaluate improvements in disease symptoms will be carried out by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), part of the Department of Health and Human Services' National Institutes of Health.

5 Aug 2004

Researchers study whether people’s genetic makeup could make them more likely to develop osteoarthritis of the knee and hip

Researchers at The University of Nottingham are studying whether people’s genetic makeup could make them more likely to develop osteoarthritis of the knee and hip — the most common medical condition to affect the joints.

3 Aug 2004

Health web sites providing bogus information to peddle alternative medicinal treatments

Researchers from the University of Exeter in England have found that cancer patients are being mislead by many popular health web sites providing bogus information to peddle alternative medicinal treatments.

3 Aug 2004

Joint inflammation

Members of the baby boomer generation are beginning to reach their 50s and 60s and seniors are living longer than ever, causing a large influx of older men and women in our society.

2 Aug 2004

Key signal in mice that tells stem cells to commit to becoming fat cells

The Hopkins team discovered that adding a single protein, dubbed BMP4, induced mouse stem cells to become fat cells. A very similar signal is likely to be involved in humans, too, say the scientists.

21 Jun 2004

Results from study of Rituxan in rheumatoid arthritis show promise

Genentech, Inc., Biogen Idec and Roche have announced that the New England Journal of Medicine published the results of a Phase IIa study showing that two doses of Rituxan® (Rituximab), administered two weeks apart, improved symptoms in patients with moderate-to-severe rheumatoid arthritis (RA) for up to 48 weeks when combined with methotrexate (MTX), compared to MTX alone.

16 Jun 2004

Australia's CSIRO to exhibit major display at the world's largest biotechnology conference

CSIRO is mounting a major display of technologies this week at BIO 2004, the world's largest biotechnology conference, being held in San Francisco, USA, from 6-9 June.

7 Jun 2004